Playing with bone and fat
暂无分享,去创建一个
J. Gimble | M. Kassem | S. Zvonic | M. Nuttall | Z. Floyd | Sanjin Zvonic
[1] J. Gimble,et al. Bone and fat , 2004, Endocrine.
[2] R. Martin,et al. Bone marrow fat content in relation to bone remodeling and serum chemistry in intact and ovariectomized dogs , 1990, Calcified Tissue International.
[3] F. Guilak,et al. Clonal analysis of the differentiation potential of human adipose‐derived adult stem cells , 2006, Journal of cellular physiology.
[4] L. Suva,et al. Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat. , 2006, Bone.
[5] J. Glowacki,et al. Adipocyte differentiation in Sod2(-/-) and Sod2(+/+) murine bone marrow stromal cells is associated with low antioxidant pools. , 2005, Experimental hematology.
[6] R. Izadpanah,et al. Characterization of multipotent mesenchymal stem cells from the bone marrow of rhesus macaques. , 2005, Stem cells and development.
[7] B. Aronow,et al. Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9. , 2005, Bone.
[8] Thomas Benjamin,et al. TAZ, a Transcriptional Modulator of Mesenchymal Stem Cell Differentiation , 2005, Science.
[9] M. Lafage-Proust,et al. Leptin modulates both resorption and formation while preventing disuse-induced bone loss in tail-suspended female rats. , 2005, Endocrinology.
[10] M. Orth,et al. Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice. , 2005, Endocrinology.
[11] Caiying Guo,et al. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation , 2005, Nature Genetics.
[12] Eijiro Watanabe,et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[13] F. Guilak,et al. Influence of oxygen on the proliferation and metabolism of adipose derived adult stem cells , 2005, Journal of cellular physiology.
[14] J. Glowacki,et al. Hypoxia Inhibition of Adipocytogenesis in Human Bone Marrow Stromal Cells Requires Transforming Growth Factor-β/Smad3 Signaling* , 2005, Journal of Biological Chemistry.
[15] M. Hamrick,et al. Leptin Treatment Induces Loss of Bone Marrow Adipocytes and Increases Bone Formation in Leptin‐Deficient ob/ob Mice , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] C. Dani,et al. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse , 2005, The Journal of experimental medicine.
[17] J. Aubin,et al. Estrogen Receptor-Related Receptor α: A Mediator of Estrogen Response in Bone , 2005 .
[18] C. Ohlsson,et al. Increased adipogenesis in bone marrow but decreased bone mineral density in mice devoid of thyroid hormone receptors. , 2005, Bone.
[19] M. Macoritto,et al. 1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6). , 2005, American journal of physiology. Endocrinology and metabolism.
[20] K. A. Wilson,et al. Col1a1 Promoter-targeted Expression of p20 CCAAT Enhancer-binding Protein β (C/EBPβ), a Truncated C/EBPβ Isoform, Causes Osteopenia in Transgenic Mice* , 2005, Journal of Biological Chemistry.
[21] J. Glowacki,et al. Increased longevity of hematopoiesis in continuous bone marrow cultures and adipocytogenesis in marrow stromal cells derived from Smad3(-/-) mice. , 2005, Experimental hematology.
[22] T. Yoneda,et al. A CCAAT/Enhancer Binding Protein β Isoform, Liver-Enriched Inhibitory Protein, Regulates Commitment of Osteoblasts and Adipocytes , 2005, Molecular and Cellular Biology.
[23] C. Robin,et al. Mesenchymal progenitor cells localize within hematopoietic sites throughout ontogeny , 2005, Development.
[24] A. Parfitt,et al. Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. , 2005, Endocrinology.
[25] O. Fromigué,et al. Transforming growth factor-β inhibits CCAAT/enhancer-binding protein expression and PPARγ activity in unloaded bone marrow stromal cells , 2005 .
[26] Jifeng Zhang,et al. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Aubin,et al. Estrogen receptor-related receptor alpha: a mediator of estrogen response in bone. , 2005, The Journal of clinical endocrinology and metabolism.
[28] G. Gronowicz,et al. Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice. , 2005, The Journal of biological chemistry.
[29] O. Fromigué,et al. Transforming growth factor-beta inhibits CCAAT/enhancer-binding protein expression and PPARgamma activity in unloaded bone marrow stromal cells. , 2005, Experimental cell research.
[30] Kozo Nakamura,et al. Distinct effects of PPARγ insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells , 2005, Journal of Bone and Mineral Metabolism.
[31] F. Jakob,et al. Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation , 2005, Cell Communication and Signaling.
[32] Moustapha Kassem,et al. Induction of Adipocyte‐Like Phenotype in Human Mesenchymal Stem Cells by Hypoxia , 2004, Stem cells.
[33] B. Lecka-Czernik,et al. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR‐γ2 transcription factor and TGF‐β/BMP signaling pathways , 2004, Aging cell.
[34] G. Watkins,et al. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. , 2004, Endocrine-related cancer.
[35] M. Bouxsein,et al. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. , 2004, Bone.
[36] L. Pénicaud,et al. Human bone marrow adipocytes support complete myeloid and lymphoid differentiation from human CD34+ cells , 2004, British journal of haematology.
[37] Miya Ishihara,et al. Osteogenic Potential of Human Adipose Tissue-Derived Stromal Cells as an Alternative Stem Cell Source , 2004, Cells Tissues Organs.
[38] S. Farmer,et al. Regulating the Balance between Peroxisome Proliferator-activated Receptor γ and β-Catenin Signaling during Adipogenesis , 2004, Journal of Biological Chemistry.
[39] R. Nusse,et al. The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.
[40] J. Auwerx,et al. Enhanced bone formation in lipodystrophic PPARγhyp/hyp mice relocates haematopoiesis to the spleen , 2004, EMBO reports.
[41] J. Peters,et al. PPARβ/δ potentiates PPARγ‐stimulated adipocyte differentiation , 2004 .
[42] J. Flier,et al. Regulated Production of a Peroxisome Proliferator-activated Receptor-γ Ligand during an Early Phase of Adipocyte Differentiation in 3T3-L1 Adipocytes* , 2004, Journal of Biological Chemistry.
[43] Y. Bae,et al. Characterization and Expression Analysis of Mesenchymal Stem Cells from Human Bone Marrow and Adipose Tissue , 2004, Cellular Physiology and Biochemistry.
[44] K. Seuwen,et al. Enhanced Marrow Adipogenesis and Bone Resorption in Estrogen-Deprived Rats Treated with the PPARgamma Agonist BRL49653 (Rosiglitazone) , 2004, Calcified Tissue International.
[45] J. Gimble,et al. Human adipose-derived adult stem cells produce osteoid in vivo. , 2004, Tissue engineering.
[46] M. Kassem,et al. Subcutaneous adipocytes can differentiate into bone-forming cells in vitro and in vivo. , 2004, Tissue engineering.
[47] F. Wezeman,et al. Adipogenic effect of alcohol on human bone marrow-derived mesenchymal stem cells. , 2004, Alcoholism, clinical and experimental research.
[48] J. Gimble,et al. Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. , 2004, Current opinion in pharmacology.
[49] T. Yanagawa,et al. Induction of osteoblast differentiation indices by statins in MC3T3‐E1 cells , 2004, Journal of cellular biochemistry.
[50] R. Tuan,et al. Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[51] Su‐Li Cheng,et al. Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis , 2004, Journal of Cell Science.
[52] T. Jensen,et al. Regulation of Human Skeletal Stem Cells Differentiation by Dlk1/Pref‐1 , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[53] C. Löwik,et al. The Balance Between Concurrent Activation of ERs and PPARs Determines Daidzein‐Induced Osteogenesis and Adipogenesis , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[54] D. Shouhed,et al. Oxysterols Regulate Differentiation of Mesenchymal Stem Cells: Pro‐Bone and Anti‐Fat , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[55] Jong Bae Seo,et al. Activated Liver X Receptors Stimulate Adipocyte Differentiation through Induction of Peroxisome Proliferator-Activated Receptor γ Expression , 2004, Molecular and Cellular Biology.
[56] J. Seckl,et al. Mice deficient in 11beta-hydroxysteroid dehydrogenase type 1 lack bone marrow adipocytes, but maintain normal bone formation. , 2004, Endocrinology.
[57] Christopher S. Chen,et al. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. , 2004, Developmental cell.
[58] R. Chiusaroli,et al. ΔFosB Induces Osteosclerosis and Decreases Adipogenesis by Two Independent Cell-Autonomous Mechanisms , 2004, Molecular and Cellular Biology.
[59] P. Tontonoz,et al. Liver X receptors are regulators of adipocyte gene expression but not differentiation: identification of apoD as a direct target. , 2004, Journal of lipid research.
[60] Kozo Nakamura,et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. , 2004, The Journal of clinical investigation.
[61] D. Xie,et al. Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. , 2004, Bone.
[62] M. Macoritto,et al. 1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARγ2) , 2004, Experimental Gerontology.
[63] F. Wezeman,et al. Inhibitory effect of alcohol on osteogenic differentiation in human bone marrow-derived mesenchymal stem cells. , 2004, Alcoholism, clinical and experimental research.
[64] T. Pennimpede,et al. The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. , 2004, Endocrinology.
[65] J. Glowacki,et al. Cooperation Between TGF‐β and Wnt Pathways During Chondrocyte and Adipocyte Differentiation of Human Marrow Stromal Cells , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[66] G. Sukhikh,et al. Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.
[67] M. Macoritto,et al. Vitamin D treatment of senescence accelerated mice (SAM-P/6) induces several regulators of stromal cell plasticity , 2004, Biogerontology.
[68] J. Peters,et al. PPARbeta/delta potentiates PPARgamma-stimulated adipocyte differentiation. , 2004, The FASEB Journal.
[69] M. Macoritto,et al. 1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2). , 2004, Experimental gerontology.
[70] S. Farmer,et al. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes. , 2004, The Journal of biological chemistry.
[71] O. Fromigué,et al. Plasticity and regulation of human bone marrow stromal osteoprogenitor cells: potential implication in the treatment of age-related bone loss. , 2004, Histology and histopathology.
[72] L. Suva,et al. Bone is a target for the antidiabetic compound rosiglitazone. , 2004, Endocrinology.
[73] D. Rao,et al. Intraclonal plasticity for bone, smooth muscle, and adipocyte lineages in bone marrow stroma fibroblastoid cells. , 2003, Experimental cell research.
[74] D. Scadden,et al. Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.
[75] Haiyang Huang,et al. Identification of the haematopoietic stem cell niche and control of the niche size , 2003, Nature.
[76] J. Gimble. Adipose tissue-derived therapeutics , 2003, Expert opinion on biological therapy.
[77] G. Duque. Will reducing adopogenesis in bone increase bone mass?: PPARgamma2 as a key target in the treatment of age-related bone loss. , 2003, Drug news & perspectives.
[78] J. A. Robinson,et al. High Bone Mass in Mice Expressing a Mutant LRP5 Gene , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[79] F. Parhami. Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor? , 2003, Prostaglandins, leukotrienes, and essential fatty acids.
[80] T. Maeda,et al. Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation. , 2003, Endocrinology.
[81] J. Gustafsson,et al. On the role of liver X receptors in lipid accumulation in adipocytes. , 2003, Molecular endocrinology.
[82] Farshid Guilak,et al. Differentiation potential of adipose derived adult stem (ADAS) cells. , 2003, Current topics in developmental biology.
[83] Min Zhu,et al. Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.
[84] S. Khosla. Leptin-central or peripheral to the regulation of bone metabolism? , 2002, Endocrinology.
[85] F. Parhami,et al. Role of the Cholesterol Biosynthetic Pathway in Osteoblastic Differentiation of Marrow Stromal Cells , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[86] Patricia Ducy,et al. Leptin Regulates Bone Formation via the Sympathetic Nervous System , 2002, Cell.
[87] J Denton,et al. Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis , 2002, Journal of clinical pathology.
[88] J. Aubin,et al. Estrogen receptor-related receptor alpha impinges on the estrogen axis in bone: potential function in osteoporosis. , 2002, Endocrinology.
[89] J. Aubin,et al. Differential Expression of Estrogen Receptor‐Related Receptor α and Estrogen Receptors α and β in Osteoblasts In Vivo and In Vitro , 2002 .
[90] H. Sul,et al. Mice Lacking Paternally Expressed Pref-1/Dlk1 Display Growth Retardation and Accelerated Adiposity , 2002, Molecular and Cellular Biology.
[91] David E. Misek,et al. Microarray Analyses during Adipogenesis: Understanding the Effects of Wnt Signaling on Adipogenesis and the Roles of Liver X Receptor α in Adipocyte Metabolism , 2002, Molecular and Cellular Biology.
[92] J. Kirkland,et al. Adipogenesis and aging: does aging make fat go MAD? , 2002, Experimental Gerontology.
[93] Toshio Matsumoto,et al. Estrogen Promotes Early Osteoblast Differentiation and Inhibits Adipocyte Differentiation in Mouse Bone Marrow Stromal Cell Lines That Express Estrogen Receptor (er) ␣ or  , 2022 .
[94] J. Lehmann,et al. Printed in U.S.A. Copyright © 2002 by The Endocrine Society Divergent Effects of Selective Peroxisome Proliferator- Activated Receptor-�2 Ligands on Adipocyte Versus Osteoblast Differentiation , 2022 .
[95] J. Lenhard,et al. Select HIV Protease Inhibitors Alter Bone and Fat Metabolismex Vivo * , 2002, The Journal of Biological Chemistry.
[96] Richard P Lifton,et al. High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.
[97] Ivan Lobov,et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.
[98] X. Holy,et al. Transforming Growth Factor β2 Inhibits Adipocyte Differentiation Induced by Skeletal Unloading in Rat Bone Marrow Stroma , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[99] T. Rando,et al. Activation of an adipogenic program in adult myoblasts with age , 2002, Mechanisms of Ageing and Development.
[100] Zhong Yun,et al. Inhibition of PPAR gamma 2 gene expression by the HIF-1-regulated gene DEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. , 2002, Developmental cell.
[101] M. Karperien,et al. Exposure of KS483 Cells to Estrogen Enhances Osteogenesis and Inhibits Adipogenesis , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[102] G. Duque,et al. Age-Related Bone Loss: Old Bone, New Facts , 2002, Gerontology.
[103] J. Lehmann,et al. Divergent Effects of Selective Peroxisome Proliferator-Activated Receptor- (cid:1) 2 Ligands on Adipocyte Versus Osteoblast Differentiation , 2002 .
[104] Mark L. Johnson,et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. , 2002, American journal of human genetics.
[105] Toshio Matsumoto,et al. Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. , 2002, Endocrinology.
[106] S. Gerson,et al. Adult bone marrow stem cells for cell and gene therapies: Implications for greater use , 2002, Journal of cellular biochemistry. Supplement.
[107] J. Aubin,et al. Differential expression of estrogen receptor-related receptor alpha and estrogen receptors alpha and beta in osteoblasts in vivo and in vitro. , 2002, Journal of Bone and Mineral Research.
[108] C. Hartmann,et al. Cbfa 1-independent decrease in osteoblast proliferation , osteopenia , and persistent embryonic eye vascularization in mice deficient in Lrp 5 , a Wnt coreceptor , 2002 .
[109] W. Wilkison,et al. Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. , 2001, Tissue engineering.
[110] Miikka Vikkula,et al. LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.
[111] T Kobayashi,et al. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. , 2001, Genes & development.
[112] M. Kassem,et al. [Mesenchymal stem cells. Potential use in cell and gene therapy of bone loss caused by aging and osteoporosis]. , 2001, Ugeskrift for laeger.
[113] F. Wezeman,et al. Bone marrow triglyceride accumulation and hormonal changes during long-term alcohol intake in male and female rats. , 2001, Alcoholism, clinical and experimental research.
[114] J. Glowacki,et al. Age‐related decline in the osteogenic potential of human bone marrow cells cultured in three‐dimensional collagen sponges , 2001, Journal of cellular biochemistry.
[115] H. Schöler,et al. Oct‐4: Gatekeeper in the Beginnings of Mammalian Development , 2001, Stem cells.
[116] E. Falk,et al. Troglitazone Treatment Increases Bone Marrow Adipose Tissue Volume but Does not Affect Trabecular Bone Volume in Mice , 2001, Calcified Tissue International.
[117] A. Caplan,et al. Cultivation of rat marrow‐derived mesenchymal stem cells in reduced oxygen tension: Effects on in vitro and in vivo osteochondrogenesis , 2001, Journal of cellular physiology.
[118] J. Aubin,et al. The Orphan Nuclear Estrogen Receptor–Related Receptor α (Errα) Is Expressed Throughout Osteoblast Differentiation and Regulates Bone Formation in Vitro , 2001, The Journal of cell biology.
[119] W. Wilkison,et al. Thiazolidinediones and glucocorticoids synergistically induce differentiation of human adipose tissue stromal cells: biochemical, cellular, and molecular analysis. , 2001, Metabolism: clinical and experimental.
[120] H. Lorenz,et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.
[121] T. Maeda,et al. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells. , 2001, Biochemical and biophysical research communications.
[122] J. Gimble,et al. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? , 2000, Bone.
[123] J. Glowacki,et al. Age-related decline in osteoprotegerin expression by human bone marrow cells cultured in three-dimensional collagen sponges. , 2000, Biochemical and biophysical research communications.
[124] Arndt F Schilling,et al. Leptin Inhibits Bone Formation through a Hypothalamic Relay A Central Control of Bone Mass , 2000, Cell.
[125] S. Harris,et al. Stimulation of bone formation in vitro and in rodents by statins. , 1999, Science.
[126] N. Nardi,et al. The hematopoietic stroma. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[127] M. Pittenger,et al. Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.
[128] M. Jensen,et al. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. , 1999, Endocrinology.
[129] V. Goldberg,et al. The Effect of Implants Loaded with Autologous Mesenchymal Stem Cells on the Healing of Canine Segmental Bone Defects* , 1998, The Journal of bone and joint surgery. American volume.
[130] J. Glowacki,et al. In vitro secretion of cytokines by human bone marrow: effects of age and estrogen status. , 1998, The Journal of clinical endocrinology and metabolism.
[131] M. Nuttall,et al. Human Trabecular Bone Cells Are Able to Express Both Osteoblastic and Adipocytic Phenotype: Implications for Osteopenic Disorders , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[132] A. Parfitt,et al. Increased Adipogenesis and Myelopoiesis in the Bone Marrow of SAMP6, a Murine Model of Defective Osteoblastogenesis and Low Turnover Osteopenia , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[133] H. Sul,et al. Cleavage of membrane-associated pref-1 generates a soluble inhibitor of adipocyte differentiation , 1997, Molecular and cellular biology.
[134] J. Lehmann,et al. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. , 1996, Molecular pharmacology.
[135] J. Gimble,et al. The function of adipocytes in the bone marrow stroma: an update. , 1996, Bone.
[136] D. Mangelsdorf,et al. An oxysterol signalling pathway mediated by the nuclear receptor LXRα , 1996, Nature.
[137] C. Koch,et al. Adaptation of chondrocytes to low oxygen tension: Relationship between hypoxia and cellular metabolism , 1996, Journal of cellular physiology.
[138] J. Gimble,et al. Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells , 1995, Journal of cellular biochemistry.
[139] K. Umesono,et al. LXR, a nuclear receptor that defines a distinct retinoid response pathway. , 1995, Genes & development.
[140] K. Medina,et al. Pregnancy-related steroids are potential negative regulators of B lymphopoiesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[141] R. Taichman,et al. Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor , 1994, The Journal of experimental medicine.
[142] H. Sul,et al. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation , 1993, Cell.
[143] J. Gimble,et al. Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells , 1993, Journal of cellular physiology.
[144] J. Greenberger,et al. Adipogenesis in a myeloid supporting bone marrow stromal cell line , 1992, Journal of cellular biochemistry.
[145] C. Devlin,et al. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. , 1992, Journal of cell science.
[146] R. Martin,et al. Relationships between marrow fat and bone turnover in ovariectomized and intact rats. , 1991, Bone.
[147] J. Gimble. The function of adipocytes in the bone marrow stroma. , 1990, The New biologist.
[148] J. Gimble,et al. Adipogenesis in a murine bone marrow stromal cell line capable of supporting B lineage lymphocyte growth and proliferation: Biochemical and molecular characterization , 1990, European journal of immunology.
[149] J. Gimble,et al. Cells and molecules that regulate B lymphopoiesis in bone marrow. , 1989, Annual review of immunology.
[150] M. Tavassoli. Marrow adipose cells and hemopoiesis: an interpretative review. , 1984, Experimental hematology.
[151] P Meunier,et al. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. , 1971, Clinical orthopaedics and related research.
[152] C S PETTY,et al. NORMAL VARIATIONS WITH AGING OF THE AMOUNT OF HEMATOPOIETIC TISSUE IN BONE MARROW FROM THE ANTERIOR ILIAC CREST. A STUDY MADE FROM 177 CASES OF SUDDEN DEATH EXAMINED BY NECROPSY. , 1965, American journal of clinical pathology.
[153] A. Vost. OSTEOPOROSIS: A NECROPSY STUDY OF VERTEBRAE AND ILIAC CRESTS. , 1963, The American journal of pathology.
[154] R. Custer,et al. Studies on the structure and function of bone marrow , 1932 .